サマリー

無血清細胞凍結保存培地の世界市場は、2024年には2億4,305万米ドルとなり、2031年には4億6,653万米ドルに達すると予測され、2025年から2031年にかけて8.05%のCAGRで成長すると予測されています。
この調査レポートは、無血清細胞凍結保存培地の世界市場について、地域別・国別、タイプ別、用途別の分析とともに、総販売量、販売収益、価格、主要企業の市場シェア、ランキングに焦点を当てて包括的に紹介することを目的としています。

無血清細胞凍結保存培地の市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データと予測データとともに、販売量（Kリットル）と販売収入（百万ドル）で提供されます。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、無血清細胞凍結保存培地に関する十分な情報に基づいたビジネス上の意思決定を行えるよう支援します。

市場区分
企業別
サーモフィッシャー
メルク
ゼノアック
ステムセル
サイティバ
バイオライフソリューションズ
富士フイルム
ロンザ
ザルトリウス
日本ジェネティクス
ハイメディア
プロモセル

タイプ別セグメント
DMSOあり
DMSOフリー

用途別セグメント
製薬・バイオテクノロジー
学術・研究機関

地域別
北米
米国
カナダ
メキシコ

アジア太平洋
中国
日本
韓国
東南アジア
インド
その他のアジア太平洋地域

欧州
ドイツ
英国
フランス
ロシア
イタリア
その他のヨーロッパ

ラテンアメリカ
ブラジル
アルゼンチン
その他のラテンアメリカ

中東・アフリカ
中東
アフリカ

各章の概要
第1章： レポートの対象範囲、世界の総市場規模（金額、数量、価格）を紹介します。本章ではまた、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。
第2章：無血清細胞凍結保存液メーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、M&A情報などを詳細に分析。
第3章：タイプ別に様々な市場セグメントの分析を提供し、各市場セグメントの市場規模や発展可能性を網羅し、読者が様々な市場セグメントにおけるブルーオーシャン市場を見つけるのに役立つ。
第4章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのに役立ちます。
第5章：無血清細胞凍結保存液の地域別売上高、収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場空間、市場規模を紹介しています。
第6章：無血清細胞凍結保存液の国別売上高、収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。
第7章：主要企業のプロファイルを提供し、製品の売上高、収益、価格、粗利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。
第8章：産業の上流と下流を含む産業チェーンの分析。
第9章：結論

ページTOPに戻る

目次

1 Market Overview 1
1.1 Serum-Free Cell Cryopreservation Medium Product Introduction 1
1.2 Global Serum-Free Cell Cryopreservation Medium Market Size Forecast 2
1.2.1 Global Serum-Free Cell Cryopreservation Medium Sales Value (2020-2031) 2
1.2.2 Global Serum-Free Cell Cryopreservation Medium Sales Volume (2020-2031) 4
1.2.3 Global Serum-Free Cell Cryopreservation Medium Sales Price (2020-2031) 5
1.3 Serum-Free Cell Cryopreservation Medium Market Trends & Drivers 5
1.3.1 Serum-Free Cell Cryopreservation Medium Industry Trends 5
1.3.2 Serum-Free Cell Cryopreservation Medium Market Drivers & Opportunity 7
1.3.3 Serum-Free Cell Cryopreservation Medium Market Challenges 8
1.3.4 Serum-Free Cell Cryopreservation Medium Market Restraints 9
1.4 Assumptions and Limitations 10
1.5 Study Objectives 11
1.6 Years Considered 12
2 Competitive Analysis by Company 13
2.1 Global Serum-Free Cell Cryopreservation Medium Players Revenue Ranking (2024) 13
2.2 Global Serum-Free Cell Cryopreservation Medium Revenue by Company (2020-2025) 14
2.3 Global Serum-Free Cell Cryopreservation Medium Players Sales Volume Ranking (2024) 15
2.4 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Company Players (2020-2025) 16
2.5 Global Serum-Free Cell Cryopreservation Medium Average Price by Company (2020-2025) 18
2.6 Key Manufacturers Serum-Free Cell Cryopreservation Medium Manufacturing Base and Headquarters 19
2.7 Key Manufacturers Serum-Free Cell Cryopreservation Medium Product Offered 20
2.8 Key Manufacturers Time to Begin Mass Production of Serum-Free Cell Cryopreservation Medium 20
2.9 Serum-Free Cell Cryopreservation Medium Market Competitive Analysis 21
2.9.1 Serum-Free Cell Cryopreservation Medium Market Concentration Rate (2020-2025) 21
2.9.2 Global 5 and 10 Largest Manufacturers by Serum-Free Cell Cryopreservation Medium Revenue in 2024 23
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Serum-Free Cell Cryopreservation Medium as of 2024) 24
2.10 Mergers & Acquisitions, Expansion 25
3 Segmentation by Type 26
3.1 Introduction by Type 26
3.1.1 With DMSO 26
3.1.2 DMSO-free 27
3.2 Global Serum-Free Cell Cryopreservation Medium Sales Value by Type 27
3.2.1 Global Serum-Free Cell Cryopreservation Medium Sales Value by Type (2020 VS 2024 VS 2031) 28
3.2.2 Global Serum-Free Cell Cryopreservation Medium Sales Value, by Type (2020-2031) 29
3.2.3 Global Serum-Free Cell Cryopreservation Medium Sales Value, by Type (%) (2020-2031) 30
3.3 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Type 31
3.3.1 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Type (2020 VS 2024 VS 2031) 31
3.3.2 Global Serum-Free Cell Cryopreservation Medium Sales Volume, by Type (2020-2031) 32
3.3.3 Global Serum-Free Cell Cryopreservation Medium Sales Volume, by Type (%) (2020-2031) 33
3.4 Global Serum-Free Cell Cryopreservation Medium Average Price by Type (2020-2031) 34
4 Segmentation by Application 35
4.1 Introduction by Application 35
4.1.1 Pharmaceutical & Biotechnology 35
4.1.2 Academic & Research Institutes 36
4.2 Global Serum-Free Cell Cryopreservation Medium Sales Value by Application 37
4.2.1 Global Serum-Free Cell Cryopreservation Medium Sales Value by Application (2020 VS 2024 VS 2031) 38
4.2.2 Global Serum-Free Cell Cryopreservation Medium Sales Value, by Application (2020-2031) 39
4.2.3 Global Serum-Free Cell Cryopreservation Medium Sales Value, by Application (%) (2020-2031) 40
4.3 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Application 41
4.3.1 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Application (2020 VS 2024 VS 2031) 41
4.3.2 Global Serum-Free Cell Cryopreservation Medium Sales Volume, by Application (2020-2031) 42
4.3.3 Global Serum-Free Cell Cryopreservation Medium Sales Volume, by Application (%) (2020-2031) 43
4.4 Global Serum-Free Cell Cryopreservation Medium Average Price by Application (2020-2031) 44
5 Segmentation by Region 45
5.1 Global Serum-Free Cell Cryopreservation Medium Sales Value by Region 45
5.1.1 Global Serum-Free Cell Cryopreservation Medium Sales Value by Region: 2020 VS 2024 VS 2031 45
5.1.2 Global Serum-Free Cell Cryopreservation Medium Sales Value by Region (2020-2025) 46
5.1.3 Global Serum-Free Cell Cryopreservation Medium Sales Value by Region (2026-2031) 46
5.1.4 Global Serum-Free Cell Cryopreservation Medium Sales Value by Region (%), (2020-2031) 47
5.2 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Region 48
5.2.1 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Region: 2020 VS 2024 VS 2031 48
5.2.2 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Region (2020-2025) 48
5.2.3 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Region (2026-2031) 49
5.2.4 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Region (%), (2020-2031) 49
5.3 Global Serum-Free Cell Cryopreservation Medium Average Price by Region (2020-2031) 50
5.4 North America 51
5.4.1 North America Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031 51
5.4.2 North America Serum-Free Cell Cryopreservation Medium Sales Value by Country (%), 2024 VS 2031 52
5.5 Europe 53
5.5.1 Europe Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031 53
5.5.2 Europe Serum-Free Cell Cryopreservation Medium Sales Value by Country (%), 2024 VS 2031 54
5.6 Asia Pacific 55
5.6.1 Asia Pacific Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031 55
5.6.2 Asia Pacific Serum-Free Cell Cryopreservation Medium Sales Value by Region (%), 2024 VS 2031 56
5.7 Latin America 57
5.7.1 Latin America Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031 57
5.7.2 Latin America Serum-Free Cell Cryopreservation Medium Sales Value by Country (%), 2024 VS 2031 58
5.8 Middle East & Africa 59
5.8.1 Middle East & Africa Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031 59
5.8.2 Middle East & Africa Serum-Free Cell Cryopreservation Medium Sales Value by Country (%), 2024 VS 2031 60
6 Segmentation by Key Countries/Regions 61
6.1 Key Countries/Regions Serum-Free Cell Cryopreservation Medium Sales Value Growth Trends, 2020 VS 2024 VS 2031 61
6.2 Key Countries/Regions Serum-Free Cell Cryopreservation Medium Sales Value 63
6.2.1 Key Countries/Regions Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031 63
6.2.2 Key Countries/Regions Serum-Free Cell Cryopreservation Medium Sales Volume, 2020-2031 66
6.3 North America 70
6.3.1 North America Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031 70
6.3.2 North America Serum-Free Cell Cryopreservation Medium Sales Value by Type (%), 2024 VS 2031 71
6.3.3 North America Serum-Free Cell Cryopreservation Medium Sales Value by Application, 2024 VS 2031 72
6.4 Europe 73
6.4.1 Europe Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031 73
6.4.2 Europe Serum-Free Cell Cryopreservation Medium Sales Value by Type (%), 2024 VS 2031 74
6.4.3 Europe Serum-Free Cell Cryopreservation Medium Sales Value by Application, 2024 VS 2031 75
6.5 China 76
6.5.1 China Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031 76
6.5.2 China Serum-Free Cell Cryopreservation Medium Sales Value by Type (%), 2024 VS 2031 77
6.5.3 China Serum-Free Cell Cryopreservation Medium Sales Value by Application, 2024 VS 2031 78
6.6 Japan 79
6.6.1 Japan Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031 79
6.6.2 Japan Serum-Free Cell Cryopreservation Medium Sales Value by Type (%), 2024 VS 2031 80
6.6.3 Japan Serum-Free Cell Cryopreservation Medium Sales Value by Application, 2024 VS 2031 81
6.7 South Korea 82
6.7.1 South Korea Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031 82
6.7.2 South Korea Serum-Free Cell Cryopreservation Medium Sales Value by Type (%), 2024 VS 2031 83
6.7.3 South Korea Serum-Free Cell Cryopreservation Medium Sales Value by Application, 2024 VS 2031 84
6.8 Southeast Asia 85
6.8.1 Southeast Asia Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031 85
6.8.2 Southeast Asia Serum-Free Cell Cryopreservation Medium Sales Value by Type (%), 2024 VS 2031 86
6.8.3 Southeast Asia Serum-Free Cell Cryopreservation Medium Sales Value by Application, 2024 VS 2031 87
6.9 India 88
6.9.1 India Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031 88
6.9.2 India Serum-Free Cell Cryopreservation Medium Sales Value by Type (%), 2024 VS 2031 89
6.9.3 India Serum-Free Cell Cryopreservation Medium Sales Value by Application, 2024 VS 2031 90
7 Company Profiles 91
7.1 Thermo Fisher 91
7.1.1 Thermo Fisher Company Information 91
7.1.2 Thermo Fisher Introduction and Business Overview 91
7.1.3 Thermo Fisher Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025) 92
7.1.4 Thermo Fisher Serum-Free Cell Cryopreservation Medium Product Offerings 92
7.2 Merck 94
7.2.1 Merck Company Information 94
7.2.2 Merck Introduction and Business Overview 94
7.2.3 Merck Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025) 95
7.2.4 Merck Serum-Free Cell Cryopreservation Medium Product Offerings 95
7.3 Zenoaq 96
7.3.1 Zenoaq Company Information 96
7.3.2 Zenoaq Introduction and Business Overview 97
7.3.3 Zenoaq Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025) 97
7.3.4 Zenoaq Serum-Free Cell Cryopreservation Medium Product Offerings 98
7.4 STEMCELL 99
7.4.1 STEMCELL Company Information 99
7.4.2 STEMCELL Introduction and Business Overview 100
7.4.3 STEMCELL Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025) 101
7.4.4 STEMCELL Serum-Free Cell Cryopreservation Medium Product Offerings 101
7.5 Cytiva 102
7.5.1 Cytiva Company Information 102
7.5.2 Cytiva Introduction and Business Overview 103
7.5.3 Cytiva Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025) 103
7.5.4 Cytiva Serum-Free Cell Cryopreservation Medium Product Offerings 104
7.6 BioLifeSolutions 105
7.6.1 BioLifeSolutions Company Information 105
7.6.2 BioLifeSolutions Introduction and Business Overview 106
7.6.3 BioLifeSolutions Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025) 106
7.6.4 BioLifeSolutions Serum-Free Cell Cryopreservation Medium Product Offerings 107
7.7 Fujifilm 109
7.7.1 Fujifilm Company Information 109
7.7.2 Fujifilm Introduction and Business Overview 109
7.7.3 Fujifilm Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025) 110
7.7.4 Fujifilm Serum-Free Cell Cryopreservation Medium Product Offerings 110
7.8 Lonza 111
7.8.1 Lonza Company Information 111
7.8.2 Lonza Introduction and Business Overview 112
7.8.3 Lonza Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025) 112
7.8.4 Lonza Serum-Free Cell Cryopreservation Medium Product Offerings 113
7.9 Sartorius (Biological Industries) 114
7.9.1 Biological Industries Company Information 114
7.9.2 Biological Industries Introduction and Business Overview 114
7.9.3 Biological Industries Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025) 115
7.9.4 Biological Industries Serum-Free Cell Cryopreservation Medium Product Offerings 115
7.10 Nippon Genetics 117
7.10.1 Nippon Genetics Company Information 117
7.10.2 Nippon Genetics Introduction and Business Overview 118
7.10.3 Nippon Genetics Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025) 118
7.10.4 Nippon Genetics Serum-Free Cell Cryopreservation Medium Product Offerings 118
7.11 HiMedia 120
7.11.1 HiMedia Company Information 120
7.11.2 HiMedia Introduction and Business Overview 121
7.11.3 HiMedia Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025) 122
7.11.4 HiMedia Serum-Free Cell Cryopreservation Medium Product Offerings 122
7.12 PromoCell 124
7.12.1 PromoCell Company Information 124
7.12.2 PromoCell Introduction and Business Overview 124
7.12.3 PromoCell Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025) 125
7.12.4 PromoCell Serum-Free Cell Cryopreservation Medium Product Offerings 125
8 Industry Chain Analysis 128
8.1 Serum-Free Cell Cryopreservation Medium Industrial Chain 128
8.2 Serum-Free Cell Cryopreservation Medium Upstream Analysis 128
8.2.1 Key Raw Materials 128
8.2.2 Raw Materials Key Suppliers 129
8.2.3 Manufacturing Cost Structure 130
8.3 Downstream Analysis (Customers Analysis) 130
8.4 Sales Model and Sales Channels 135
8.4.1 Serum-Free Cell Cryopreservation Medium Sales Model 135
8.4.2 Sales Channel 135
8.4.3 Serum-Free Cell Cryopreservation Medium Distributors 136
9 Research Findings and Conclusion 140
10 Appendix 142
10.1 Research Methodology 142
10.1.1 Methodology/Research Approach 142
10.1.2 Data Source 145
10.2 Author Details 148
10.3 Disclaimer 149